X0609 4 2026-07-08 0001034842 RIGEL PHARMACEUTICALS INC RIGL 0001645600 HANNAH ALISON L. false RIGEL PHARMACEUTICALS, INC. 611 GATEWAY BLVD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 false true false false EVP, Chief Medical Officer false Common Stock 2026-07-08 4 A false 24400 0 A 35025 D The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over four (4) years from July 8, 2026, with the first annual vest occurring on July 8, 2027. Amount has been adjusted to reflect the cancellation of 5,750 restricted stock units for no consideration, which is exempt from Section 16 pursuant to Rule 16b-6(d) and Rule 16a-4(d) promulgated under the Securities Exchange Act of 1934, as amended. /s/ Raymond Furey (Attorney-in-Fact) 2026-07-10